Yit Yang

8PUBLICATIONS
29CO-AUTHORS
Vision scienceOptical technologyMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyOphthalmology and optometry not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 15, 2024
Visual outcomes and complications of combined versus sequential pars plana vitrectomy and phacoemulsification for epiretinal membrane.

Yousef A Fouad, Mohamed K Soliman, Abdelrahman M Elhusseiny

|Jun 08, 2022
Correction: Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies.

David R Lally, Anat Loewenstein, Jennifer J Arnold

|May 21, 2022
Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies.

David R Lally, Anat Loewenstein, Jennifer J Arnold

|Mar 22, 2022
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice.

Ian Pearce, Winfried Amoaku, Clare Bailey

|Oct 13, 2021
Novel metrics for evaluating decision making in a 'Treat and Extend' regimen for neovascular age related macular degeneration.

Bethan McLeish, Anna Morris, Meena Karpoor

|Jun 16, 2021
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Philip Hykin, A Toby Prevost, Sobha Sivaprasad

Pageof 2

Frequent Collaborators

2 joint publications

Anat Loewenstein

2 joint publications

Sobha Sivaprasad

1 joint publications

William Fusi-Rubiano

1 joint publications

Yousef A Fouad